Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma

被引:0
作者
Pinilla, I. [4 ]
Gomez-Leon, N. [4 ]
Del Campo-Del Val, L. [1 ]
Hernandez-Maraver, D. [2 ]
Rodriguez-Vigil, B. [4 ]
Jover-Diaz, R. [3 ]
Coya, J. [4 ]
机构
[1] Hosp Univ Princesa, Dept Radiol, Madrid, Spain
[2] Hosp Univ La Paz, Dept Hematol, Madrid 28046, Spain
[3] Unidad PET TC MDA Anderson, Madrid, Spain
[4] Hosp Univ La Paz, Dept Radiol & Nucl Med, Madrid 28046, Spain
关键词
Positron-emission tomography; Tomography; X-ray computed; Lymphoma; Neoplasm staging; POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKIN-LYMPHOMA; FDG-PET; DISEASE; INVOLVEMENT; NEED;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim. The aim of this paper was to compare the accuracy of contrast-enhanced computed tomography (CT), positron emission tomography (PET), unenhanced low-dose PET/CT (LD-PET/CT) and full-dose enhanced PET/CT (FD-PET/CT) for the initial staging of lymphoma. Methods. One hundred and one lymphoma patients were examined by [18F]FDG-PET/CT including unenhanced low-dose CT and enhanced full-dose CT. Each modality of PET/CT was evaluated by a nuclear medicine physician and a radiologist unaware of the other modality, while the CT and PET images were interpreted separately by another independent radiologist and nuclear medicine physician respectively. The nodal and extranodal lesions detected by each technique were compared with a reference standard. Results. For nodal assessment, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), and negative LR (LR-) of LD-PET/CT were 97%, 96%, 98%, 95%, 26 and 0.02 respectively, and those of FD-PET/CT were 97%, 97%, 98%, 95%, 36 and 0.02. These results were significantly better than those of PET (sensitivity 82%, specificity 81%, PPV 88%, NPV 72%, LR+ 4.3, LR-0.21). Likewise, both PET/CT displayed a higher sensitivity, NPV and LR-than CT (91%, 84%, 0.1 respectively). For organ evaluation, both modalities of PET/CT also had significantly better sensitivity and NPV than that of PET (LD-PET/CT: sensitivity 92%, NPV 90%; FD-PET/CT sensitivity 94%, NPV 92%; PET: sensitivity 70%, NPV 69%). The sensitivity, specificity, PPV and NPV for bone marrow involvement were 29%, 84%, 45% and 72% respectively for PET, and 29%, 90%, 56%, and 74% for both, LD-PET/CT, and FD-PET/CT. No significant differences were found between LD-PET/CT and FDPET/CT, but FD-PET/CT detected important incidental findings in 5.9% of patients. Conclusion. PET/CT is an accurate technique for the initial staging of lymphomas without significant differences between LD-PET/CT and FD-PET/CT. FDPET/CT detects relevant incidental findings that are missed on LD-PET/CT.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 28 条
  • [1] Comparison between 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma
    Allen-Auerbach, M
    Quon, A
    Weber, WA
    Obrzut, S
    Crawford, T
    Silverman, DHS
    Ratib, O
    Phelps, ME
    Czernin, J
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (06) : 411 - 416
  • [2] Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET
    Altamirano, Javier
    Esparza, Jorge Reyes
    Salazar, Jaime de la Garza
    Calvo, Pedro Sobrevilla
    Vera, Silvia Rivas
    Revelo, Juan Ramon Chalapud
    Estrada, Gisela
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (01) : 69 - 77
  • [3] 18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease
    Ansquer, Catherine
    Hervouet, Thomas
    Devillers, Anne
    de Guibert, Sophie
    Gastinne, Thomas
    Le Gouill, Steven
    Garin, Etienne
    Moreau, Anne
    Kraeber-Bodere, Francoise
    Lamy, Thierry
    [J]. HAEMATOLOGICA, 2007, 93 (01) : 128 - 131
  • [4] Normal and abnormal patterns of 18F-Fluorodeoxyglucose PET/CT in lymphoma
    Bar-Shalom, Rachel
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2007, 45 (04) : 677 - +
  • [5] Limitations of PET for imaging lymphoma
    Barrington, Sally F.
    O'Doherty, Michael J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S117 - S127
  • [6] Beyer T, 2000, J NUCL MED, V41, P1369
  • [7] Positron emission tomography in mantle cell lymphoma
    Brepoels, Lieselot
    Stroobants, Sigrid
    De Wever, Walter
    Dierickx, Daan
    Vandenberghe, Peter
    Thomas, Jose
    Mortelmans, Luc
    Verhoef, Gregor
    De Wolf-Peeters, Christiane
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (09) : 1693 - 1701
  • [8] Utility of FDG-PET scanning in lymphoma by WHO classification
    Elstrom, R
    Guan, L
    Baker, G
    Nakhoda, K
    Vergilio, JA
    Zhuang, H
    Pitsilos, S
    Bagg, A
    Downs, L
    Mehrotra, A
    Kim, S
    Alavi, A
    Schuster, SJ
    [J]. BLOOD, 2003, 101 (10) : 3875 - 3876
  • [9] Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma
    Elstrom, R. L.
    Leonard, J. P.
    Coleman, M.
    Brown, R. K. J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (10) : 1770 - 1773
  • [10] FDG-PET/CT in re-staging of patients with lymphoma
    Freudenberg, LS
    Antoch, G
    Schütt, P
    Beyer, T
    Jentzen, W
    Müller, SP
    Görges, R
    Nowrousian, MR
    Bockisch, A
    Debatin, JF
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (03) : 325 - 329